Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood

被引：88

作者：

Hendricks, Robert ^{[1
]}

Baker, Dana ^{[1
]}

Brumm, Jochen ^{[2
]}

Davancaze, Teresa ^{[1
]}

Harp, Chris ^{[3
]}

Herman, Ann ^{[3
]}

von Budingen, H-Christian ^{[4
]}

Townsend, Michael ^{[5
]}

Fischer, Saloumeh K. ^{[1
]}

机构：

[1] Genentech Inc, Dept BioAnalyt Sci, San Francisco, CA 94080 USA

[2] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA

[3] Genentech Inc, OMNI Biomarker Dev, San Francisco, CA 94080 USA

[4] Roche, Neurosci, Prod Dev, Basel, Switzerland

[5] Genentech Inc, Biomarker Discovery OMNI, San Francisco, CA 94080 USA

来源：

BIOANALYSIS | 2019年 / 11卷 / 15期

关键词：

Alzheimer's disease (AD); amyotrophic lateral sclerosis (ALS); biomarker; cerebrospinal fluid (CSF); multiple sclerosis (MS); neurodegeneration; neurofilament light (NfL) chain; Quanterix Simoa (TM); UmanDiagnostics Nf-Light ELISA (Uman ELISA); QUANTIFICATION; BIOMARKER; SERUM;

D O I：

10.4155/bio-2019-0163

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Background: Neurofilament light (NfL) chain is an established cerebrospinal fluid (CSF) biomarker for neuroaxonal injury. The highly sensitive Quanterix SimoaT platform is evaluated for NfLmeasurement in both CSF and blood. There is a need to link historical ELISA data that use bovine NfL to that of Simoa using a recombinant human (rhuman) NfL standard. Results/Methodology: The Simoa NF-light (R) Advantage Kit was validated for CSF and qualified for serum and plasma, using both rhuman and bovine NfL calibrators. Matched CSF, serum and plasma samples from 112 multiple sclerosis patients were analyzed using both calibrators. Conclusion: In multiple sclerosis, there is a good correlation between blood and CSF NfL levels. A conversion factor of approximately 5:1 was established between bovine and rhuman NfL calibrators.

引用

页码：1405 / 1418

页数：14

共 15 条

[1] Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases [J].

Bacioglu, Mehtap ;

Maia, Luis F. ;

Preische, Oliver ;

Schelle, Juliane ;

Apel, Anja ;

Kaeser, Stephan A. ;

Schweighauser, Manuel ;

Eninger, Timo ;

Lambert, Marius ;

Pilotto, Andrea ;

Shimshek, Derya R. ;

Neumann, Ulf ;

Kahle, Philipp J. ;

Staufenbiel, Matthias ;

Neumann, Manuela ;

Maetzler, Walter ;

Kuhle, Jens ;

Jucker, Mathias .

NEURON, 2016, 91 (01) :56-66

[2] Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis [J].

Disanto, Giulio ;

Barro, Christian ;

Benkert, Pascal ;

Naegelin, Yvonne ;

Schadelin, Sabine ;

Giardiello, Antonella ;

Zecca, Chiara ;

Blennow, Kaj ;

Zetterberg, Henrik ;

Leppert, David ;

Kappos, Ludwig ;

Gobbi, Claudio ;

Kuhle, Jens .

ANNALS OF NEUROLOGY, 2017, 81 (06) :857-870

[3] Neurofilament light chain as a biomarker in neurological disorders [J].

Gaetani, Lorenzo ;

Blennow, Kaj ;

Calabresi, Paolo ;

Di Filippo, Massimiliano ;

Parnetti, Lucilla ;

Zetterberg, Henrik .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (08) :870-881

[4] Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases [J].

Gaiottino, Johanna ;

Norgren, Niklas ;

Dobson, Ruth ;

Topping, Joanne ;

Nissim, Ahuva ;

Malaspina, Andrea ;

Bestwick, Jonathan P. ;

Monsch, Andreas U. ;

Regeniter, Axel ;

Lindberg, Raija L. ;

Kappos, Ludwig ;

Leppert, David ;

Petzold, Axel ;

Giovannoni, Gavin ;

Kuhle, Jens .

PLOS ONE, 2013, 8 (09)

[5] Neurofilament Light in Serum and Cerebrospinal Fluid of Hip Fracture Patients with Delirium [J].

Halaas, Nathalie Bodd ;

Blennow, Kaj ;

Idland, Ane-Victoria ;

Wyller, Torgeir Bruun ;

Raeder, Johan ;

Frihagen, Frede ;

Staff, Anne Cathrine ;

Zetterberg, Henrik ;

Watne, Leiv Otto .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2018, 46 (5-6) :346-357

[6] Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug development [J].

Khan, Masood U. ;

Bowsher, Ronald R. ;

Cameron, Mark ;

Devanarayan, Viswanath ;

Keller, Steve ;

King, Lindsay ;

Lee, Jean ;

Morimoto, Alyssa ;

Rhyne, Paul ;

Stephen, Laurie ;

Wu, Yuling ;

Wyant, Timothy ;

Lachno, D. Richard .

BIOANALYSIS, 2015, 7 (02) :229-242

[7] Blood neurofilament light chain as a biomarker of MS disease activity and treatment response [J].

Kuhle, Jens ;

Kropshofer, Harald ;

Haering, Dieter A. ;

Kundu, Uma ;

Meinert, Rolf ;

Barro, Christian ;

Dahlke, Frank ;

Tomic, Davorka ;

Leppert, David ;

Kappos, Ludwig .

NEUROLOGY, 2019, 92 (10) :E1007-E1015

[8] Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity [J].

Kuhle, Jens ;

Barro, Christian ;

Disanto, Giulio ;

Mathias, Amandine ;

Soneson, Charlotte ;

Bonnier, Guillaume ;

Yaldizli, Oezguer ;

Regeniter, Axel ;

Derfuss, Tobias ;

Canales, Mathieu ;

Schluep, Myriam ;

Du Pasquier, Renaud ;

Krueger, Gunnar ;

Granziera, Cristina .

MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (12) :1550-1559

[9] Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa [J].

Kuhle, Jens ;

Barro, Christian ;

Andreasson, Ulf ;

Derfuss, Tobias ;

Lindberg, Raija ;

Sandelius, Asa ;

Liman, Victor ;

Norgren, Niklas ;

Blennow, Kaj ;

Zetterberg, Henrik .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (10) :1655-1661

[10] Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease [J].

Lin, Yung-Shuan ;

Lee, Wei-Ju ;

Wang, Shuu-Jiun ;

Fuh, Jong-Ling .

SCIENTIFIC REPORTS, 2018, 8

← 1 2 →